Tumorinfiltrating

Health

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment

The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma,…

Read More »
Back to top button